Cardiovascular Renal Metabolic

Emily Morris, Oliver J Rider

Read time: 19m 30s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
New Horizons in Obesity Management 2026

Angela Fitch, Richard Hobbs, Nikolaus Marx

AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The CORALreef HeFH Trial

Christie Ballantyne

Watch time: 5m 9s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)

Christopher Henry Grant, Samira Bell

Read time: 19m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s

Andrew JS Coats, Stefan Anker

AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s
EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 5m 20s

Emily Morris, Oliver J Rider

Read time: 19m 30s
EP 111: ACC 24 in Review With Dr Vallabhajosyula: 5 Trials That Will Change Your Practice

Listen time: 1h 11m 26s
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)

Fausto J Pinto, John Spertus, , et al

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)
EP 54: 5 Trials that will change your practice: Review of ESC 21 with Dr Purvi Parwani

Ankur Kalra, Purvi Parwani,

Listen time: 1h 17s

Joost Daemen, Nicolas M Van Mieghem

David K Ryan, Debasish Banerjee, Fadi Jouhra

Read time: 10m

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Media

Yassir Javaid, ,

Watch time: 42m 25s (4 videos)

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
New Horizons in Obesity Management 2026

Angela Fitch, Richard Hobbs, Nikolaus Marx

Broadcast

Cardiovascular Renal Metabolic

Heart Failure
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano, Aaron Wong , et al

Watch time: 1h 3m 30s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Managing Hypertension in CVD: How Low Can We Go?

Yassir Javaid, Michel Burnier, Mariya Tokmakova , et al

Watch time: 57m 24s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar, Liesbeth van Rossum , et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
AOM 2024

Harold Bays, Naveed Sattar, Mikhail Kosiborod , et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2024 - Day 2

Antonio Ceriello, Adeera Levin, Ileana L Piña , et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2024 - Day 1

Antonio Ceriello, Adeera Levin, Ileana L Piña , et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day Two

Stefan Anker, Javed Butler, Antonio Ceriello , et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day One

Stefan Anker, Javed Butler, Antonio Ceriello , et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Nocturnal Hypertension

Roland Asmar, Melanie Dunwell, Matthew Capehorn , et al

Watch time: 1h 9m 26s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s

Articles

Gaps in Modern Heart Failure and Chronic Kidney Disease Research

Simran Singh Parmar

,

Vasantha Muthuppalaniappan

,

Debasish Banerjee

,

Published:

23 August 2023

Citation:

European Cardiology Review 2023;18:e51.

DOI:

https://doi.org/10.15420/ecr.2022.64
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 127
  • Citations: 7
  • Read time: 5m

Timing of SGLT2 Inhibitors in Heart Failure

Moritake Iguchi

,

Hiromichi Wada

,

Felipe Martínez

,

Koji Hasegawa

,

Published:

07 June 2023

Citation:

European Cardiology Review 2023;18:e41.

DOI:

https://doi.org/10.15420/ecr.2022.62
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 217
  • Citations: 3
  • Read time: 9m 20s

Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver Disease

Daciana Dascalu

,

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e23.

DOI:

https://doi.org/10.15420/ecr.2023.18.PO6
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 44
  • Citations: 1
  • Read time: 1m

LDL-C Reduction in Diabetic Patients after Percutaneous Coronary Intervention: Is There any Difference with Non-diabetic?

N Mallofré Vila

,

G Torres-Ruiz

,

C Roca-Guerrero

,

P Rojas-Flores

,

M Sutil-Vega

,

Núria Casanovas

,

M Lloreda

,

F Castaldo

,

Eduardo Bosch-Peligero

,

Antoni Martínez-Rubio

,

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e19.

DOI:

https://doi.org/10.15420/ecr.2023.18.PO2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 35
  • Read time: 8m 40s